Viewing StudyNCT00195624



Ignite Creation Date: 2024-05-05 @ 11:59 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00195624
Status: COMPLETED
Last Update Posted: 2020-07-07
First Post: 2005-09-16

Brief Title: Alemtuzumab to Treat Severe Aplastic Anemia
Sponsor: National Heart Lung and Blood Institute NHLBI
Organization: National Institutes of Health Clinical Center CC

Conditions & Keywords Data

Conditions:
Name
Severe Aplastic Anemia Relapse
Severe Aplastic Anemia Refractory
Keywords:
Name View
SAA View
Immunosuppression View
T-cells View
Hematopoiesis View
Autoimmunity View
Thrombocytopenia View
Severe Aplastic Anemia View